new data protection law

The Implications of India’s New Data Protection Law on Internal Investigations

Internal investigations may need to be carried out in India by employers in relation to a wide range of issues and/or situations. In case of Indian subsidiaries of MNCs, investigations may be carried out for the purpose of satisfying compliance requirements under law(s) applicable to the parent entity, like the Foreign Corrupt Practices Act of 1977 of the US or the UK’s Bribery Act 2010.
In the course of such internal investigations, large amounts of personal data related to accused persons and other relevant individuals may need to be processed by the employer – either by itself or through its advisors and agents. Accordingly, an informed assessment of the rights of such individuals, as well as the obligations of the employer and its advisors/agents, becomes crucial from the perspective of applicable data protection law.
This note specifically discusses the processing of personal data in the context of internal investigations, including with respect to allegations or suspicions of economic and criminal offences. While necessary rules under the Digital Personal Data Protection Act, 2023 are yet to be notified, provisions of this new law, as published in August 2023, indicate key considerations for employers (each of which is likely to be treated as a “data fiduciary”), including with respect to consent, legitimate use and potential exemptions.


related party transactions

Related Party Transactions: Recent SEBI Scrutiny

The Securities and Exchange Board of India (“SEBI”) has been continuously calibrating the disclosure requirements applicable to Indian listed companies to increase transparency and accessibility of information to investors. Provisions regulating related party transactions (“RPTs”), and appropriate disclosure of such transactions, are a step in that direction. This note discusses two recent SEBI actions against listed companies related to RPTs and highlights the need for listed companies to have a comprehensive policy on RPTs that suitably addresses any perceived gaps or ambiguities.


front running trades

Decoding Front Running Trades

Front running trades are trades where an investor has placed an order in a stock while in possession of “non-public information” of “a substantial impending transaction” in that stock. Such trades not only distort the level playing field in the securities market by taking advantage of unequal information acquired through unfair means but also affect market integrity. This note tracks the evolution of jurisprudence related to front running in India and highlights the interpretational challenges and evidentiary issues relating to front running trades.


Indo-Pacific Economic Framework

The Indo-Pacific Economic Framework for Prosperity: Opportunities for Indian Companies

Along with 13 other countries (including the US, Japan, Singapore, South Korea and Australia), India has joined the Indo-Pacific Economic Framework for Prosperity (“IPEF”). Representing 40% of global GDP and almost 30% of international trade in goods and services, the IPEF is expected to promote economic activity, investment, and sustainable growth in the Indo-Pacific region. It also aims to address emerging economic challenges – such as those related to trade, supply chains, clean energy (including green infrastructure), taxation and anti-corruption.
While agreements in respect of a clean economy and a fair economy, respectively, were reached in June 2024 at the IPEF Ministerial meeting held in Singapore, the IPEF agreement on supply chains, signed in November 2023, came into force earlier this year (February 2024).
The IPEF presents a unique opportunity for Indian companies to enhance competitiveness and expand their markets. By actively engaging with the framework, businesses in India can position themselves as key players in the dynamic Indo-Pacific landscape. Further, the IPEF presents an opportunity for India to strengthen economic cooperation with the US – which relationship, in turn, is likely to prove valuable for both Indian and American companies.


pharmaceutical marketing practices

A New Code for Pharmaceutical Marketing Practices: From Symptoms to Diagnosis

Pursuant to a notification dated March 12, 2024, the Department of Pharmaceuticals under India’s Ministry of Chemicals and Fertilizers issued a new uniform code for pharmaceutical marketing practices (the “New Code”), replacing a decade-old version of the same code (the “Old Code”).
The New Code applies to both pharmaceutical and medical device companies and aims to provide operational clarity around promotional activities undertaken by such companies. Although several key themes of the Old Code have been retained, a more balanced approach with respect to educational events and items has been introduced. Further, while it has been generally strengthened relative to the Old Code – including in respect of penalties, complaints and appeals, along with the possibility of future standing orders – the New Code remains voluntary, although an explicit reference to its voluntary nature has now been omitted.


Enforcement of Securities Law

Global Investigations Review: The Guide to International Enforcement of the Securities Laws (Second Edition)

We are pleased to present the India chapter of the Global Investigations Review’s Guide to International Enforcement of the Securities Laws (Second Edition). The India chapter has been authored by Niti Dixit, Shahezad Kazi, Zahra Aziz and Gladwin Issac, all lawyers at S&R.
The India chapter provides information on relevant statutes and the government authorities responsible for investigating and enforcing them, conduct most commonly the subject of securities enforcement, and legal issues that commonly arise in enforcement investigations in India.